Sid Yadav, Breast and GYN Oncologist in Women’s Cancer Program at Mayo Clinic Comprehensive Cancer Center, posted on X:
“CDK4/6 inhibitors in GYN cancers:
In this 3 part podcast with SGO, we discuss the indications for CDK4/6 inhibitors in uterine and ovarian cancers, potential toxicities, required monitoring, and some practical tips in administering these drugs.”
Podcast attached to the post.